Understanding the pathophysiology of the asthma-chronic obstructive pulmonary disease overlap syndrome.
Pulmonary Division, Department of Medicine, Lakewood Regional Medical Center (LRMC), Lakewood, and the Geffen School of Medicine at UCLA Medical Center, Los Angeles, Calif. Electronic address: afgelb@msn.com.
Arthur F
AF
Gelb
Departments of Medicine, Physiology, and Radiology, University of California, San Francisco Medical Center, San Francisco, Calif.
Jay A
JA
Nadel
D000280:Administration, Inhalation; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use*; D001249:Asthma / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology / Q000503:physiopathology; D003937:Diagnosis, Differential; D006801:Humans; D007111:Immunity, Cellular; D018727:Muscarinic Antagonists / Q000627:therapeutic use; D010641:Phenotype; D029424:Pulmonary Disease, Chronic Obstructive / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology / Q000503:physiopathology; D018418:Th2 Cells / Q000187:drug effects / Q000276:immunology / Q000473:pathology*
D000305:Adrenal Cortex Hormones; D000318:Adrenergic beta-Agonists; D018927:Anti-Asthmatic Agents; D018727:Muscarinic Antagonists
Asthma; COPD; asthma-COPD overlap syndrome; emphysema